Journals / Turkish Journal of Endocrinology and Metabolism / 2021 / Cilt: 25 - Sayı: 2

Serum Paraoxonase-1 Activity and ParaoxonaseQ192 Gene Polymorphism in a Young,Healthy Population

Sağlıklı Genç Popülasyonda Serum Paraoksonaz-1 Aktivitesi ve Paraoksonaz Q192 Gen Polimorfizmi

Pages
193–201
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PON Q192 gene polymorphism could be a determinant of PON acti-vity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Paraoxonase-1 (PON1) enzyme and PON Q192Rgene polymorphism are associated with atherosclerosis in many middle-aged individuals and high populations at risk of cardio-vascular disease.
📊
Key Findings & Data:This study aimed to determine serum PON-1 and arylesterase (ARE) activities, PON Q192R polymorphism, and their association with gender, lipoprotein levels, and caro-tid intima-media thickness (CIMT) among young healthy indivi-duals.
💡
Conclusion & Impact:PON Q192 gene polymorphism could be a determinant of PON acti-vity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Paraoxonase-1 (PON1) enzyme and PON Q192Rgene polymorphism are associated with atherosclerosis in many middle-aged individuals and high populations at risk of cardio-vascular disease. This study aimed to determine serum PON-1 and arylesterase (ARE) activities, PON Q192R polymorphism, and their association with gender, lipoprotein levels, and caro-tid intima-media thickness (CIMT) among young healthy indivi-duals. Material and Methods: Four hundred fifteen healthyvolunteers (F/M: 213/202, 19-25 years) were included in the study. Serum lipoprotein levels and PON1, ARE activities were measured using spectrophotometric methods. PON 192Q poly-morphism was evaluated by polymerase chain reaction, and CIMT was measured using Doppler ultrasonography. Results:Serum PON1 activity and PON Q192R polymorphism frequen-cies were similar between men and women, while ARE activity was significantly higher in women. PON1 activity was conside-rably higher in RR carriers than in QQ and QR carriers among both men and women. Serum high-density lipoprotein level was lower, and CIMT was higher in men compared to women. Con- clusion: PON1 enzyme activities did not differ according to gen- der, and ARE activity was higher in women. High PON1 activity is associated with PONQ192 RR polymorphism carriers. PON Q192 gene polymorphism could be a determinant of PON acti-vity.

Özet

Amaç: Paraoksonaz-1 (PON1) aktivitesi ve Q192R gen polimor- fizminin kardiyovasküler riskii yüksek ve yaşlı popülasyonlardaateroskleroz ile ilişkisi gösterilmiştir. Bu çalışmanın amacı, sağ- lıklı genç popülasyonda serum PON-1 ve arilesteraz (ARE) akti- vitelerini ölçmek ve bu düzeylerin cinsiyet, lipoprotein düzeyleri, PON Q192R gen polimorfizmi ve karotis intima medya kalınlığı ile(KIMK) ilişkisini değerlendirmektir. Gereç ve Yöntemler: Dörtyüz on beş sağlıklı gönüllü (K/E: 213/202, minimum-maksimum19-25 yaş) çalışmaya dâhil edildi. Serum lipoprotein düzeyleriPON-1 ve ARE aktiviteleri spektrofotometrik yöntem ile ölçüldü. PON Q192R gen polimorfizmi polimeraz zincirleme reaksiyonu, KIMK Doppler ultrasonografi ile değerlendirildi. Bulgular:Serum ARE aktivitesi kadınlarda erkeklere göre daha yüksek bu- lundu, ancak PON1 aktiviteleri her 2 grupta benzerdi. PON Q192R gen polimorfizm sıklıkları ve dağılımları kadın ve erkek- lerde benzerdi. Tüm çalışma grubunda PON1 aktivitesi, PONQ192R RR taşıyıcılarında QQ ve QR taşıyıcılarından daha yüksekizlendi. Erkeklerde, kadın grubuna göre serum yüksek yoğun- luklu lipoprotein düzeyi düşük, KIMK ölçümü yüksek tespitedildi. Sonuç: PON1 enzim aktivitesi cinsiyete göre farklılık gös- termemiş olup, ARE aktivitesi kadınlarda daha yüksek izlenmiş- tir. PONQ192 RR polimorfizm “Yüksek PON1 aktivitesi, PONQ192RR polimorfizm taşıyıcıları ile ilişkilidir.” PON Q192R gene poli- morfizmi PON aktivitesinin belirleyicisi olabilir.

🔖

Cite This Article

ATAK, P. G., YAVUZ, D. G., APAYDIN, T., ÜSTAY, Ö., TELLİ, A., ŞİRİKÇİ, Ö. (2022). Serum Paraoxonase-1 Activity and ParaoxonaseQ192 Gene Polymorphism in a Young,Healthy Population. Turkish Journal of Endocrinology and Metabolism, Cilt: 25 - Sayı: 2, 193–201. https://ajindex.com/articles/605335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Li HL, Liu DP, Liang CC. Paraoxonase gene poly- morphisms, oxidative stress, and diseases. J Mol Med (Berl). 2003
  2. [Crossref] [PubMed] 2. Zsíros N, Koncsos P, Lőrincz H, Seres I, Katkó M, Szentpéteri A, Varga VE, Fülöp P, Paragh G, Harangi M. Paraoxonase-1 arylesterase activity is an inde- pendent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications. Clin Biochem. 2016
  3. [Crossref] [PubMed] 3. Serrato M, Marian AJ. A variant of human paraoxo- nase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest. 1995
  4. [Crossref] [PubMed] [PMC] 4. Sun T, Hu J, Yin Z, Xu Z, Zhang L, Fan L, Zhuo Y, Wang C. Low serum paraoxonase1 activity levels predict coronary artery disease severity. Oncotar- get. 2017
  5. 19443-19454. [Crossref] [PubMed] [PMC] 5. Scherrer DZ, Zago VH, Vieira IC, Parra ES, Panzoldo NB, Alexandre F, Secolin R, Baracat J, Quintão EC, Faria EC. p.Q192R SNP of PON1 seems not to be as- sociated with carotid atherosclerosis risk factors in an asymptomatic and normolipidemic Brazilian po- pulation sample. Arq Bras Cardiol. 2015
  6. [Crossref] [PubMed] [PMC] 6. Chen X, Wu Y, Liu L, Su Y, Peng Y, Jiang L, Liu X, Huang D. Relationship between high density lipop- rotein antioxidant activity and carotid arterial in- tima-media thickness in patients with essential hypertension. Clin Exp Hypertens. 2010
  7. [Crossref] [PubMed] 7. Durrington PN, Mackness B, Mackness MI. Para- oxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001
  8. [Crossref] [PubMed] 8. Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E, Roberts C, Durrington PN, Mackness MI. Paraoxonase status in coronary heart disease: are activity and concentration more important than ge- notype? Arterioscler Thromb Vasc Biol. 2001
  9. [Crossref] [PubMed] 9. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5' regulatory- region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet. 2001
  10. [Crossref] [PubMed] [PMC] 10. Lawlor DA, Day IN, Gaunt TR, Hinks LJ, Briggs PJ, Kiessling M, Timpson N, Smith GD, Ebrahim S. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet. 2004
  11. [PubMed] [PMC] 11. Ombres D, Pannitteri G, Montali A, Candeloro A, Seccareccia F, Campag